{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:22:37Z","timestamp":1782858157211,"version":"3.54.5"},"reference-count":99,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T00:00:00Z","timestamp":1704931200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Federal Service for Supervision of Consumer Protection","award":["GZ 43\/21"],"award-info":[{"award-number":["GZ 43\/21"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecules"],"abstract":"<jats:p>Cardiovascular diseases caused by blood coagulation system disorders are one of the leading causes of morbidity and mortality in the world. Research shows that blood clotting factors are involved in these thrombotic processes. Among them, factor Xa occupies a key position in the blood coagulation cascade. Another coagulation factor, XIa, is also a promising target because its inhibition can suppress thrombosis with a limited contribution to normal hemostasis. In this regard, the development of dual inhibitors as new generation anticoagulants is an urgent problem. Here we report the synthesis and evaluation of novel potential dual inhibitors of coagulation factors Xa and XIa. Based on the principles of molecular design, we selected a series of compounds that combine in their structure fragments of pyrrolo[3,2,1-ij]quinolin-2-one and thiazole, connected through a hydrazine linker. The production of new hybrid molecules was carried out using a two-stage method. The reaction of 5,6-dihydropyrrolo[3,2,1-ij]quinoline-1,2-diones with thiosemicarbazide gave the corresponding hydrazinocarbothioamides. The reaction of the latter with DMAD led to the target methyl 2-(4-oxo-2-(2-(2-oxo-5,6-dihydro-4H-pyrrolo[3,2,1-ij]quinolin-1(2H)-ylidene)hydrazineyl)thiazol-5(4H)-ylidene)acetates in high yields. In vitro testing of the synthesized molecules revealed that ten of them showed high inhibition values for both the coagulation factors Xa and XIa, and the IC50 value for some compounds was also assessed. The resulting structures were also tested for their ability to inhibit thrombin.<\/jats:p>","DOI":"10.3390\/molecules29020373","type":"journal-article","created":{"date-parts":[[2024,1,11]],"date-time":"2024-01-11T08:27:07Z","timestamp":1704961627000},"page":"373","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Design, Synthesis, and Evaluation of New Hybrid Derivatives of 5,6-Dihydro-4H-pyrrolo[3,2,1-ij]quinolin-2(1H)-one as Potential Dual Inhibitors of Blood Coagulation Factors Xa and XIa"],"prefix":"10.3390","volume":"29","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9859-6476","authenticated-orcid":false,"given":"Anna A.","family":"Skoptsova","sequence":"first","affiliation":[{"name":"Department of Organic Chemistry, Faculty of Chemistry, Voronezh State University, 1 Universitetskaya Sq., 394018 Voronezh, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9894-7777","authenticated-orcid":false,"given":"Athina","family":"Geronikaki","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Aristotle University of Thessaloniki, 54124 Thessaloniki, Greece"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8167-6093","authenticated-orcid":false,"given":"Nadezhda P.","family":"Novichikhina","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Faculty of Chemistry, Voronezh State University, 1 Universitetskaya Sq., 394018 Voronezh, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8767-642X","authenticated-orcid":false,"given":"Alexey V.","family":"Sulimov","sequence":"additional","affiliation":[{"name":"Research Computing Center, Lomonosov Moscow State University, 119992 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3612-393X","authenticated-orcid":false,"given":"Ivan S.","family":"Ilin","sequence":"additional","affiliation":[{"name":"Research Computing Center, Lomonosov Moscow State University, 119992 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7102-6107","authenticated-orcid":false,"given":"Vladimir B.","family":"Sulimov","sequence":"additional","affiliation":[{"name":"Research Computing Center, Lomonosov Moscow State University, 119992 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5623-723X","authenticated-orcid":false,"given":"Georgii A.","family":"Bykov","sequence":"additional","affiliation":[{"name":"Department of Biophysics at the Faculty of Physics, Lomonosov Moscow State University, 119992 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8013-1112","authenticated-orcid":false,"given":"Nadezhda A.","family":"Podoplelova","sequence":"additional","affiliation":[{"name":"Center for Theoretical Problems of Physicochemical Pharmakology, 119991 Moscow, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3340-8750","authenticated-orcid":false,"given":"Oleg V.","family":"Pyankov","sequence":"additional","affiliation":[{"name":"State Research Center of Virology and Biotechnology \u201cVector\u201d, 630559 Koltsovo, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6576-0305","authenticated-orcid":false,"given":"Khidmet S.","family":"Shikhaliev","sequence":"additional","affiliation":[{"name":"Department of Organic Chemistry, Faculty of Chemistry, Voronezh State University, 1 Universitetskaya Sq., 394018 Voronezh, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2024,1,11]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"2982","DOI":"10.1016\/j.jacc.2020.11.010","article-title":"Global burden of cardiovascular diseases and risk factors, 1990\u20132019: Update from the GBD 2019 study","volume":"76","author":"Roth","year":"2020","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1016\/S0140-6736(20)32439-9","article-title":"Direct oral anticoagulants: Evidence and unresolved issues","volume":"396","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"100742","DOI":"10.1016\/j.cpcardiol.2020.100742","article-title":"Thrombosis and Coagulopathy in COVID-19","volume":"46","author":"Montes","year":"2021","journal-title":"Curr. Probl. Cardiol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3390\/hematolrep15020024","article-title":"Risk of Thrombosis during and after a SARS-CoV-2 Infection: Pathogenesis, Diagnostic Approach, and Management","volume":"15","author":"Sutanto","year":"2023","journal-title":"Hematol. Rep."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2174\/138161207779313605","article-title":"Recent advances in serine protease inhibitors as anticoagulant agents","volume":"13","author":"Prezelj","year":"2007","journal-title":"Curr. Pharm. Des."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.4155\/fmc-2015-0020","article-title":"Structure\u2013activity relationship studies for multitarget antithrombotic drugs","volume":"8","author":"Neves","year":"2016","journal-title":"Future Med. Chem."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/j.1538-7836.2006.01830.x","article-title":"Inhibitors of blood coagulation factors Xa and IIa synergize to reduce thrombus weight and thrombin generation in vivo and in vitro","volume":"4","author":"Gould","year":"2006","journal-title":"J. Thromb. Haemost."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"29770","DOI":"10.1074\/jbc.M805214200","article-title":"Kinetic Characterization of the Protein Z-dependent Protease Inhibitor Reaction with Blood Coagulation Factor Xa","volume":"283","author":"Xin","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1016\/j.febslet.2009.05.009","article-title":"An anticoagulant peptide from the human hookworm, Ancylostoma duodenale that inhibits coagulation factors Xa and XIa","volume":"583","author":"Gan","year":"2009","journal-title":"FEBS Lett."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ijpara.2015.03.009","article-title":"Conserved Amblyomma americanum tick Serpin19, an inhibitor of blood clotting factors Xa and XIa, trypsin and plasmin, has anti-haemostatic functions","volume":"45","author":"Kim","year":"2015","journal-title":"Int. J. Parasitol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1016\/j.bmcl.2007.03.080","article-title":"Selective and dual action orally active inhibitors of thrombin and factor Xa","volume":"17","author":"Young","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"3322","DOI":"10.1016\/j.bmcl.2007.03.105","article-title":"From selective substrate analogue factor Xa inhibitors to dual inhibitors of thrombin and factor Xa. Part 3","volume":"17","author":"Schweinitz","year":"2007","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Remko, M., Remkov\u00e1, A., and Broer, R. (2016). Theoretical study of molecular structure and physicochemical properties of novel factor Xa inhibitors and dual factor Xa and factor IIa inhibitors. Molecules, 21.","DOI":"10.3390\/molecules21020185"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.aca.2017.07.063","article-title":"Dual-target inhibitor screening against thrombin and factor Xa simultaneously by mass spectrometry","volume":"990","author":"Xu","year":"2017","journal-title":"Anal. Chim. Acta"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1182\/blood-2011-09-381764","article-title":"Specificity and selectivity profile of EP217609: A new neutralizable dual-action anticoagulant that targets thrombin and factor Xa","volume":"119","author":"Olson","year":"2012","journal-title":"Blood"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/00019501-199607000-00003","article-title":"Potential advantages of direct-acting thrombin inhibitors","volume":"7","author":"Philippides","year":"1996","journal-title":"Coron. Artery Dis."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1161\/01.CIR.90.4.1624","article-title":"Hirudin in acute myocardial infarction. Safety report from the Thrombolysis and Thrombin Inhibition in Myocardial Infarction (TIMI) 9A Trial","volume":"90","author":"Antman","year":"1994","journal-title":"Circulation"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1161\/01.CIR.90.4.1638","article-title":"Safety observations from the pilot phase of the randomized r-Hirudin for Improvement of Thrombolysis (HIT-III) study. A study of the Arbeitsgemeinschaft Leitender Kardiologischer Krankenhaus\u00e4rzte (ALKK)","volume":"90","author":"Neuhaus","year":"1994","journal-title":"Circulation"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.hoc.2016.05.007","article-title":"The Intrinsic pathway of coagulation as a target for antithrombotic therapy","volume":"30","author":"Wheeler","year":"2016","journal-title":"Hematol. Oncol. Clin. N. Am."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.blre.2018.04.001","article-title":"Plasma contact factors as therapeutic targets","volume":"32","author":"Tillman","year":"2018","journal-title":"Blood Rev."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1002\/med.21503","article-title":"Recent advances in the discovery and development of factor XI\/XIa inhibitors","volume":"38","author":"Afosah","year":"2018","journal-title":"Med. Res. Rev."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/jth.13005","article-title":"Factor XI and contact activation as targets for antithrombotic therapy","volume":"13","author":"Gailani","year":"2015","journal-title":"J. Thromb. Haemost."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2217\/fca-2023-0051","article-title":"Asundexian: An oral small molecule factor XIa inhibitor for the treatment of thrombotic disorders","volume":"19","author":"Cave","year":"2023","journal-title":"Future Cardiol."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1021\/acsptsci.3c00052","article-title":"Determination of the potential clinical benefits of small molecule factor XIa inhibitors in arterial thrombosis","volume":"6","author":"Wichaiyo","year":"2023","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/00001721-199703000-00008","article-title":"A murine model of factor XI deficiency","volume":"8","author":"Gailani","year":"1997","journal-title":"Blood Coagul. Fibrinolysis"},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Althagafi, I., El-Metwaly, N., and Farghaly, T.A. (2019). New Series of Thiazole Derivatives: Synthesis, Structural Elucidation, Antimicrobial Activity, Molecular Modeling and MOE Docking. Molecule, 24.","DOI":"10.3390\/molecules24091741"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.18596\/jotcsa.375716","article-title":"Synthesis of Thiazole Derivatives as Antimicrobial Agents by Green Chemistry Techniques","volume":"5","author":"Demirci","year":"2018","journal-title":"J. Turk. Chem. Soc. Sect. A Chem."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Liaras, K., Fesatidou, M., and Geronikaki, A. (2018). Thiazoles and Thiazolidinones asCOX\/LOX Inhibitors. Molecule, 23.","DOI":"10.3390\/molecules23030685"},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Kumar, G., and Singh, N.P. (2021). Synthesis, anti-inflammatory and analgesic evaluation of thiazole\/oxazole substituted benzothiazole derivatives. Bioorg. Chem., 107.","DOI":"10.1016\/j.bioorg.2020.104608"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.ejmech.2017.12.038","article-title":"Design, synthesis and biological evaluations of novel pyridonethiazole hybrid molecules as antitumor agents","volume":"145","author":"Xie","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.ejmech.2017.12.040","article-title":"Synthesis, anticancer activity and mechanism of action of new thiazole derivatives","volume":"144","author":"Barbosa","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/14756366.2016.1238366","article-title":"Isatin thiazoline hybrids as dual inhibitors of HIV-1reverse transcriptase","volume":"32","author":"Meleddu","year":"2017","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2174\/1570163814666170915134018","article-title":"A Retrospect Study on Thiazole Derivatives as the Potential Antidiabetic Agents in Drug Discovery and Developments","volume":"15","author":"Khatik","year":"2018","journal-title":"Curr. Drug Discov. Technol."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1080\/14756366.2019.1654470","article-title":"Exploring new structural features of the 4-[(3-methyl-4-aryl-2,3-dihydro-1,3-thiazol-2-ylidene)amino]benzenesulphonamide scaffold for the inhibition of human carbonic anhydrases","volume":"34","author":"Distinto","year":"2019","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1080\/14756366.2020.1786820","article-title":"Synthesis and evaluation of 2,4,5-trisubstitutedthiazoles as carbonic anhydrase-III inhibitors","volume":"35","author":"Deb","year":"2020","journal-title":"J. Enzym. Inhib. Med. Chem."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejmech.2019.05.082","article-title":"Synthesis and biological evaluation of 2,4,5-trisubstituted thiazoles as antituberculosis agents effective against drug-resistant tuberculosis","volume":"178","author":"Karale","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.ejmech.2008.05.004","article-title":"Synthesis, antiarrhythmic and anticoagulant activities of novel thiazolo derivatives from methyl 2-(thiazol-2-ylcarbamoyl) acetate","volume":"44","author":"Amr","year":"2009","journal-title":"Eur. J. Med. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejmech.2015.04.025","article-title":"Design, synthesis and structure\u2013activity relationship of oxazolidinone derivatives containing novel S4 ligand as FXa inhibitors","volume":"96","author":"Zhao","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/1570163814666170725114159","article-title":"Thiazole Containing Heterocycles with Antimalarial Activity","volume":"15","author":"Kumawat","year":"2018","journal-title":"Curr. Drug Discov. Technol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Mishchenko, M., Shtrygol, S., Kaminskyy, D., and Lesyk, R. (2020). Thiazole-Bearing 4-Thiazolidinones as NewAnticonvulsant Agents. Sci. Pharm., 88.","DOI":"10.3390\/scipharm88010016"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1021\/jm401670x","article-title":"Tetrahydroquinoline derivatives as potent and selective factor XIa inhibitors","volume":"57","author":"Quan","year":"2014","journal-title":"J. Med. Chem."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"3369","DOI":"10.1038\/ncomms4369","article-title":"Delayed bactericidal response of Mycobacterium tuberculosis to bedaquiline involves remodelling of bacterial metabolism","volume":"5","author":"Koul","year":"2014","journal-title":"Nat. Commun."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1021\/acs.jmedchem.7b01417","article-title":"Design, synthesis, and evaluation of orally bioavailable quinoline-indole derivatives as innovative multitarget-directed ligands: Promotion of cell proliferation in the adult murine hippocampus for the treatment of Alzheimer\u2019s disease","volume":"61","author":"Wang","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.2174\/15680266113139990133","article-title":"Insight View on Possible Role of Fluoroquinolones in Cancer Therapy","volume":"13","author":"Sharma","year":"2013","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"4081","DOI":"10.1016\/j.bmc.2019.07.035","article-title":"Synthesis of quinoline derivatives as diabetic II inhibitors and molecular docking studies","volume":"27","author":"Taha","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/j.ejmech.2018.01.080","article-title":"Fluoroquinolone Derivatives and Their Anti-tubercular Activities","volume":"146","author":"Fan","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0141-3910(02)00285-9","article-title":"Antioxidant activity of the fused heterocyclic compounds, 1,2,3,4-tetrahydroquinolines, and related compounds\u2014Effect of ortho-substituents","volume":"79","author":"Nishiyama","year":"2003","journal-title":"Polym. Degrad. Stab."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"2000086","DOI":"10.1002\/ardp.202000086","article-title":"Quinoline-based promising anticancer and antibacterial agents, and some metabolic enzyme inhibitors","volume":"353","author":"Erkan","year":"2020","journal-title":"Arch. Pharm."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3923\/ajdd.2012.40.49","article-title":"Synthesis of some pyrrole derivatives and their Anticoagulant Activity","volume":"2","author":"Idhayadhulla","year":"2012","journal-title":"Am. J. Drug Discov. Dev."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2478\/v10007-009-0016-9","article-title":"Synthesis of certain pyrrole derivatives as antimicrobial agents","volume":"59","author":"Mohamed","year":"2009","journal-title":"Acta Pharm."},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Said Fatahala, S., Hasabelnaby, S., Goudah, A., Mahmoud, G.I., and Helmy Abd-El Hameed, R. (2017). Pyrrole and fused pyrrole compounds with bioactivity against inflammatory mediators. Molecules, 22.","DOI":"10.3390\/molecules22030461"},{"key":"ref_52","first-page":"49","article-title":"Synthesis of pyrroles and condensed pyrroles as anti-inflammatory agents with multiple activities and their molecular docking study","volume":"5","author":"Sarg","year":"2015","journal-title":"Open J. Med. Chem."},{"key":"ref_53","first-page":"24","article-title":"Pyrrole as an important scaffold of anticancer drugs: Recent advances","volume":"25","author":"Mateev","year":"2022","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Bianco, M.D.C.A.D., Marinho, D.I.L.F., Hoelz, L.V.B., Bastos, M.M., and Boechat, N. (2021). Pyrroles as privileged scaffolds in the search for new potential HIV inhibitors. Pharmaceuticals, 14.","DOI":"10.3390\/ph14090893"},{"key":"ref_55","doi-asserted-by":"crossref","unstructured":"Novichikhina, N., Ilin, I., Tashchilova, A., Sulimov, A., Kutov, D., Ledenyova, I., Krysin, M., Shikhaliev, K., Gantseva, A., and Gantseva, E. (2020). Synthesis, Docking, and In Vitro Anticoagulant Activity Assay of Hybrid Derivatives of Pyrrolo [3,2,1-ij]Quinolin-2(1H)-one as New Inhibitors of Factor Xa and Factor XIa. Molecules, 25.","DOI":"10.3390\/molecules25081889"},{"key":"ref_56","doi-asserted-by":"crossref","unstructured":"Novichikhina, N.P., Shestakov, A.S., Medvedeva, S.M., Lagutina, A.M., Krysin, M.Y., Podoplelova, N.A., Panteleev, M.A., Ilin, I.S., Sulimov, A.V., and Tashchilova, A.S. (2023). New Hybrid Tetrahydropyrrolo[3,2,1-ij]quinolin-1-ylidene-2-thioxothiazolidin-4-ones as New Inhibitors of Factor Xa and Factor XIa: Design, Synthesis, and In Silico and Experimental Evaluation. Molecules, 28.","DOI":"10.3390\/molecules28093851"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s11094-018-1726-4","article-title":"Synthesis, docking, and anticoagulant activity of new factor-Xa inhibitors in a series of pyrrolo[3,2,1-ij]quinoline-1,2-diones","volume":"51","author":"Medvedeva","year":"2018","journal-title":"Pharm. Chem. J."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1007\/s11172-022-3615-y","article-title":"Synthesis and properties of novel hybrid molecules bearing 4H-pyrrolo[3,2,1-ij]quinolin-2-one and thiazole moieties","volume":"71","author":"Novichikhina","year":"2022","journal-title":"Russ. Chem. Bull."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1134\/S1070428020090080","article-title":"Synthesis and anticoagulant activity of new ethylidene and spiro derivatives of Pyrrolo[3,2,1-ij]quinolin-2-ones","volume":"56","author":"Novichikhina","year":"2020","journal-title":"Russ. J. Org. Chem."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"e202200730","DOI":"10.1002\/slct.202200730","article-title":"Reaction of 1-Phenacylidene pyrrolo [3,2,1-ij] quinolin-2-ones with Cyclic\/Acyclic Enaminones and the Anticoagulant Activity of Synthesized Pyrrole-Quinoline Derivatives","volume":"7","author":"Skoptsova","year":"2022","journal-title":"ChemistrySelect"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.bmcl.2005.10.013","article-title":"Design, synthesis, and vasorelaxant and platelet antiaggregatory activities of coumarin\u2013resveratrol hybrids","volume":"16","author":"Vilar","year":"2006","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"63187","DOI":"10.18632\/oncotarget.18730","article-title":"Structure based design, synthesis and activity studies of small hybrid molecules as HDAC and G9a dual inhibitors","volume":"8","author":"Zang","year":"2017","journal-title":"Oncotarget"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1016\/j.bmcl.2014.05.018","article-title":"Synthesis of novel 4-nitropyrrole-based semicarbazide and thiosemicarbazide hybrids with antimicrobial and anti-tubercular activity","volume":"24","author":"Rane","year":"2014","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1002\/ddr.21594","article-title":"Synthesis, biological evaluation, and molecular modeling of nitrile-containing compounds: Exploring multiple activities as anti-Alzheimer agents","volume":"81","author":"Silva","year":"2020","journal-title":"Drug Dev. Res."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s00706-018-2292-x","article-title":"Synthesis, characterization, and evaluation of antioxidant and antibacterial activities of novel indole-hydrazono thiazolidinones","volume":"149","author":"Asghari","year":"2018","journal-title":"Monatshefte Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"6810","DOI":"10.1016\/j.tet.2012.06.049","article-title":"Synthesis and anti-leukaemic activity of pyrrolo[3,2,1-hi]indole-1,2-diones, pyrrolo[3,2,1-ij]quinoline-1,2-diones and other polycyclic isatin derivatives","volume":"68","author":"Matesic","year":"2012","journal-title":"Tetrahedron"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ejmech.2016.05.039","article-title":"Contemporary developments in the discovery of selective factor Xa inhibitors: A review","volume":"121","author":"Patel","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"7956","DOI":"10.1016\/j.bmc.2008.07.065","article-title":"Design and synthesis of a metabolically stable and potent antitussive agent, a novel \u03b4 opioid receptor antagonist, TRK-851","volume":"16","author":"Sakami","year":"2008","journal-title":"Bioorg. Med. Chem."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.bmcl.2018.01.027","article-title":"Design, synthesis and biological evaluation of novel pyrazolo-oxothiazolidine derivatives as antiproliferative agents against human lung cancer cell line A549","volume":"28","author":"Yakaiah","year":"2018","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"ref_70","doi-asserted-by":"crossref","unstructured":"Gomha, S.M., Salaheldin, T.A., Hassaneen, H.M., Abdel-Aziz, H.M., and Khedr, M.A. (2015). Synthesis, characterization and molecular docking of novel bioactive thiazolyl-thiazole derivatives as promising cytotoxic antitumor drug. Molecules, 21.","DOI":"10.3390\/molecules21010003"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"456","DOI":"10.2174\/1570179412666150828195202","article-title":"Synthesis of new thiazole derivatives as antitumor agents","volume":"13","author":"Abbas","year":"2016","journal-title":"Curr. Org. Synth."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1080\/07391102.2021.2018045","article-title":"Structural and functional insight into thiazolidinone derivatives as novel candidates for anticancer drug design: In vitro biological and in-silico strategies","volume":"41","author":"Channar","year":"2023","journal-title":"J. Biomol. Struct. Dyn."},{"key":"ref_73","doi-asserted-by":"crossref","unstructured":"Alzahrani, A.Y., Ammar, Y.A., Abu-Elghait, M., Salem, M.A., Assiri, M.A., Ali, T.E., and Ragab, A. (2022). Development of novel indolin-2-one derivative incorporating thiazole moiety as DHFR and quorum sensing inhibitors: Synthesis, antimicrobial, and antibiofilm activities with molecular modelling study. Bioorg. Chem., 119.","DOI":"10.1016\/j.bioorg.2021.105571"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.1002\/slct.201900679","article-title":"Synthesis and antimicrobial activity of novel thiazoles with reactive functional groups","volume":"4","author":"Stasevych","year":"2019","journal-title":"ChemistrySelect"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1007\/s13738-018-1431-y","article-title":"Semi-synthesis, antibacterial and antifungal activities of three novel thiazolidin-4-one by essential oil of Anethum graveolens seeds as starting material","volume":"15","author":"Ahani","year":"2018","journal-title":"J. Iran. Chem. Soc."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"131662","DOI":"10.1016\/j.molstruc.2021.131662","article-title":"A facile one pot multi component synthesis of alkyl 4-oxo-coumarinyl ethylidene hydrazono-thiazolidin-5-ylidene acetates and their antiviral activity","volume":"1249","author":"Vaarla","year":"2022","journal-title":"J. Mol. Struct."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ardp.201300057","article-title":"Synthesis and Antiviral Activity of New Substituted Methyl [2-(arylmethylene-hydrazino)-4-oxo-thiazolidin-5-ylidene] acetates","volume":"346","author":"Saeed","year":"2013","journal-title":"Arch. Pharm."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1080\/00397911.2019.1638938","article-title":"Antioxidant activity of some N-heterocycles derived from 2-(1-(2-oxo-2 H-chromen-3-yl) ethylidene) hydrazinecarbothioamide","volume":"49","author":"Sallam","year":"2019","journal-title":"Synth. Commun."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.molstruc.2018.07.085","article-title":"Prospective new amidinothiazoles as leukotriene B4 inhibitors","volume":"1175","author":"Aly","year":"2019","journal-title":"J. Mol. Struct."},{"key":"ref_80","unstructured":"Kato, M., Ito, K., and Yamanaka, T. (1995). New Heterocyclic Derivative. (JPH07285952A), Japanese Patent."},{"key":"ref_81","first-page":"105","article-title":"New functional derivatives 4,4,6-trimethyl-4H-pyrrolo[3,2,1-ij]quinoline-1,2-diones","volume":"46","author":"Leshcheva","year":"2003","journal-title":"Izv. Vuzov. Khimiya Khim. Tekhnologia [ChemChemTech]"},{"key":"ref_82","doi-asserted-by":"crossref","unstructured":"Aly, A.A., Mohamed, N.K., Hassan, A.A., El-Shaieb, K.M., Makhlouf, M.M., Br\u00e4se, S., Nieger, M., and Brown, A.B. (2019). Functionalized 1,3-Thiazolidin-4-Ones from 2-Oxo-Acenaphthoquinylidene-and [2.2] Paracyclophanylidene-Thiosemicarbazones. Molecules, 24.","DOI":"10.3390\/molecules24173069"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.14233\/ajchem.2017.20678","article-title":"Synthesis of 3-Substituted Pyrido[1,2-a]pyrimidinethylidenehydrazinylthiozole Derivatives from Pyridine-2-amines","volume":"29","author":"Venkateswarlu","year":"2017","journal-title":"Asian J. Chem."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1002\/jhet.712","article-title":"Reactions of dimethyl ethynedicarboxylate with (substituted ethylidene) hydrazinecarbothioamides","volume":"50","author":"Hassan","year":"2013","journal-title":"J. Heterocycl. Chem."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"134906","DOI":"10.1016\/j.molstruc.2023.134906","article-title":"Synthesis, crystal structure and evaluation of anticancer activities of some novel heterocyclic compounds based on thymol","volume":"1278","author":"Laamari","year":"2023","journal-title":"J. Mol. Struct."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1080\/10426507.2015.1073282","article-title":"Efficient \u201con water\u201d green route heterocyclization of thiosemicarbazones with DMAD","volume":"191","author":"Singla","year":"2016","journal-title":"Phosphorus Sulfur Silicon Relat. Elem."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1134\/S1070428006060017","article-title":"Condensations of thioamides with acetylenecarboxylic acid derivatives","volume":"42","author":"Danilkina","year":"2006","journal-title":"Russ. J. Org. Chem."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1055\/s-0037-1617095","article-title":"Rivaroxaban","volume":"27","author":"Perzborn","year":"2007","journal-title":"H\u00e4mostaseologie"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2174\/1568026013395461","article-title":"The use of 3D structural data in the design of specific factor Xa inhibitors","volume":"1","author":"Maignan","year":"2001","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1021\/ci400094h","article-title":"Application of the Docking Program SOL for CSAR Benchmark","volume":"53","author":"Sulimov","year":"2013","journal-title":"J. Chem. Inf. Model."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:5\/6<490::AID-JCC1>3.0.CO;2-P","article-title":"Merck molecular force field. I. Basis, form, scope, parameterization, and performance of MMFF94","volume":"17","author":"Halgren","year":"1996","journal-title":"J. Comput. Chem."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"9323","DOI":"10.1021\/jp046721s","article-title":"Surface Generalized Born method: A simple, fast, and precise implicit solvent model beyond the Coulomb approximation","volume":"108","author":"Romanov","year":"2004","journal-title":"J. Phys. Chem. A"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jmgm.2019.03.017","article-title":"New factor Xa inhibitors based on 1,2,3,4-tetrahydroquinoline developed by molecular modelling","volume":"89","author":"Ilin","year":"2019","journal-title":"J. Mol. Graph. Model."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s11172-020-2834-3","article-title":"Synthesis of 4H-pyrrolo[3,2,1-ij]quinoline-1,2-diones containing a piperazine fragment and study of their inhibitory properties against protein kinases","volume":"69","author":"Novichikhina","year":"2020","journal-title":"Russ. Chem. Bull."},{"key":"ref_95","doi-asserted-by":"crossref","unstructured":"Sulimov, A., Ilin, I., Kutov, D., Shikhaliev, K., Shcherbakov, D., Pyankov, O., Stolpovskaya, N., Medvedeva, S., and Sulimov, V. (2022). New Chemicals Suppressing SARS-CoV-2 Replication in Cell Culture. Molecules, 27.","DOI":"10.3390\/molecules27175732"},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1134\/S1995080221070222","article-title":"Supercomputing, Docking and Quantum Mechanics in Quest for Inhibitors of Papain-like Protease of SARS-CoV-2","volume":"42","author":"Sulimov","year":"2021","journal-title":"Lobachevskii J. Math."},{"key":"ref_97","unstructured":"ChemAxon (2022, February 10). Marvin was Used for Drawing, Displaying and Characterizing Chemical Structures, Substructures and Reactions, Marvin 21.3.0. Available online: https:\/\/chemaxon.com\/products\/marvin."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/1758-2946-3-33","article-title":"Open Babel: An open chemical toolbox","volume":"3","author":"Banck","year":"2011","journal-title":"J. Cheminform."},{"key":"ref_99","first-page":"4","article-title":"Supercomputer Lomonosov-2: Large scale, deep monitoring and fine analytics for the user community","volume":"6","author":"Voevodin","year":"2019","journal-title":"Supercomput. Front. Innov."}],"container-title":["Molecules"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/2\/373\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T13:44:46Z","timestamp":1760103886000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1420-3049\/29\/2\/373"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,11]]},"references-count":99,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,1]]}},"alternative-id":["molecules29020373"],"URL":"https:\/\/doi.org\/10.3390\/molecules29020373","relation":{},"ISSN":["1420-3049"],"issn-type":[{"value":"1420-3049","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,11]]}}}